Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 21
Results: 28
End‐of‐life impact of concurrent diabetes mellitus and adrenal insufficiency as immune‐related adverse events in an advanced non‐small cell lung cancer patient.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3073, doi. 10.1111/1759-7714.14660
- By:
- Publication type:
- Article
Pazopanib for treating rhabdomyosarcoma in adult patients with poor performance status: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3080, doi. 10.1111/1759-7714.14669
- By:
- Publication type:
- Article
Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3076, doi. 10.1111/1759-7714.14662
- By:
- Publication type:
- Article
The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3052, doi. 10.1111/1759-7714.14658
- By:
- Publication type:
- Article
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3042, doi. 10.1111/1759-7714.14657
- By:
- Publication type:
- Article
MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3032, doi. 10.1111/1759-7714.14656
- By:
- Publication type:
- Article
A case of multiple primary lung adenocarcinoma with a CD74‐NRG1 fusion protein and HER2 mutation benefit from combined target therapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3063, doi. 10.1111/1759-7714.14636
- By:
- Publication type:
- Article
Evaluation of <sup>99m</sup>Tc‐3PRGD<sub>2</sub> SPECT imaging on angiogenesis in animal models of lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3025, doi. 10.1111/1759-7714.14655
- By:
- Publication type:
- Article
Controversial role of mast cells in NSCLC tumor progression and angiogenesis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2929, doi. 10.1111/1759-7714.14654
- By:
- Publication type:
- Article
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3018, doi. 10.1111/1759-7714.14653
- By:
- Publication type:
- Article
Exosome‐delivered circSATB2 targets the miR‐330‐5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3007, doi. 10.1111/1759-7714.14652
- By:
- Publication type:
- Article
Esophageal submucosal tumor diagnosed with EBUS‐guided transbronchial mediastinal cryobiopsy: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3068, doi. 10.1111/1759-7714.14650
- By:
- Publication type:
- Article
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3101, doi. 10.1111/1759-7714.14651
- By:
- Publication type:
- Article
Evaluation of pulmonary artery bleeding during thoracoscopic pulmonary resection for lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3001, doi. 10.1111/1759-7714.14649
- By:
- Publication type:
- Article
miR‐92a‐3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2992, doi. 10.1111/1759-7714.14648
- By:
- Publication type:
- Article
Adaptation criterion for segmentectomy in small‐sized early stage non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2985, doi. 10.1111/1759-7714.14647
- By:
- Publication type:
- Article
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3058, doi. 10.1111/1759-7714.14646
- By:
- Publication type:
- Article
Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2978, doi. 10.1111/1759-7714.14645
- By:
- Publication type:
- Article
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3084, doi. 10.1111/1759-7714.14644
- By:
- Publication type:
- Article
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
- By:
- Publication type:
- Article
The risk and prognostic factors for liver metastases in esophageal cancer patients: A large‐cohort based study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2960, doi. 10.1111/1759-7714.14642
- By:
- Publication type:
- Article
Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3099, doi. 10.1111/1759-7714.14641
- By:
- Publication type:
- Article
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2951, doi. 10.1111/1759-7714.14635
- By:
- Publication type:
- Article
Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 3098, doi. 10.1111/1759-7714.14619
- Publication type:
- Article
Construction of PEI‐EGFR‐PD‐L1‐siRNA dual functional nano‐vaccine and therapeutic efficacy evaluation for lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2941, doi. 10.1111/1759-7714.14618
- By:
- Publication type:
- Article
Invasive area to tumor ratio is a significant prognostic factor for non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2935, doi. 10.1111/1759-7714.14616
- By:
- Publication type:
- Article
Feasibility and oncological outcomes of video‐assisted thoracic surgery versus thoracotomy for pathologic N2 disease in non–small cell lung cancer: A comprehensive systematic review and meta‐analysis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2917, doi. 10.1111/1759-7714.14614
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2915, doi. 10.1111/1759-7714.14035
- Publication type:
- Article